Skip to product information
1 of 1

Management of Non-Muscle Invasive Bladder Cancer - Clinical

Management of Non-Muscle Invasive Bladder Cancer - Clinical

Regular price $54.99 USD

Price subject to change. Tap below for current.

In this review of Management of Non-Muscle Invasive Bladder Cancer the authors present a focused clinical resource aimed at clinicians who manage early-stage bladder cancer. The bottom line: this book is best for trainees and practising medical professionals who need a concise, evidence-based guide to diagnostic options and the range of therapeutic techniques for non-muscle invasive disease. The review finds the book particularly useful because it organizes guidance in uniformly formatted chapters that make it straightforward to apply recommendations in clinical practice.

Key Features

  • Comprehensive evidence review: Each chapter synthesizes current evidence on efficacy for diagnostic procedures and therapeutic options so clinicians can evaluate choices against the literature.
  • Uniform chapter format: Consistent structure across topics helps readers rapidly find indications, techniques and practical application guidance during patient care.
  • Practical treatment guidance: Clear, clinically oriented recommendations support decision making for a range of available therapeutic treatments relevant to non-muscle invasive bladder cancer.
  • Focus on risk factors and diagnostics: The book reviews risk factors and diagnostic procedures in a way that supports risk stratification and surveillance planning.
  • Targeted for clinicians: Material is tailored to trainee and practising medical professionals who treat these patients, emphasizing applicability over general interest.

Who It's For

This book is directed squarely at urology trainees, general urologists, oncologists and other medical professionals involved in bladder cancer care who need an up-to-date, concise clinical reference. It suits those who prefer evidence summaries and practical treatment notes rather than long theoretical texts.

Clinicians seeking patient-facing lay explanations or an exhaustive research monograph may want a different resource; this volume is best used as a hands-on clinical guide and companion to broader textbooks or guideline documents.

Pros & Cons

Pros

  • Well organized chapters make it quick to locate guidance on specific therapeutic techniques or diagnostics.
  • Evidence-based summaries help translate trial data into practical clinical decisions.
  • Designed for clinicians, so content emphasizes applicability to everyday patient care.

Cons

  • Not intended as a patient education resource, so lay explanations are limited.

Specifications

Title Management of Non-Muscle Invasive Bladder Cancer
Authors Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala
Scope Therapeutic techniques, diagnostics and risk factors
Audience Trainee and practising medical professionals
Content focus Evidence review and practical guidance
Format Uniformly formatted chapters for clinical application

Our Verdict

Management of Non-Muscle Invasive Bladder Cancer is a concise, clinically focused reference that delivers practical, evidence-based guidance for clinicians who manage early-stage bladder cancer. It represents good value for trainees and practising urologists who want clear recommendations and diagnostic review without wading through long textbooks.

Frequently Asked Questions

Does this book cover diagnostic procedures?
The text reviews diagnostic procedures and discusses their role in risk stratification and surveillance planning.

Who wrote this book?
It is authored by Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala and David Albala, aiming at clinical readers.

Is it suitable for patient education?
No, the book is written for clinicians; patients will find the material too technical and should be given simplified resources.

Editor's Take

GearMustHave editorial rating: 4.2 out of 5. GearMustHave Editorial Rating

A concise, clinically focused reference that delivers practical, evidence-based guidance for trainees and practising urologists managing non-muscle invasive bladder cancer; good value for clinicians seeking applicable recommendations.

View full details
Management of Non-Muscle Invasive Bladder Cancer - Clinical
Management of Non-Muscle Invasive Bladder Cancer - Clinical
Regular price $54.99 USD
CHECK AVAILABILITY ➤

Recently viewed